 , Agents Causing Muscle Toxicity , Albumins , Amino Acids, Peptides, and Proteins , Antimitotic Agents , Antineoplastic Agents , Antineoplastic Agents, Phytogenic , Antineoplastic and Immunomodulating Agents , BSEP/ABCB11 Inhibitors , BSEP/ABCB11 Substrates , BSEP/ABCB11 Substrates with a Narrow Therapeutic Index , Cardiotoxic antineoplastic agents , Cyclodecanes , Cycloparaffins , Cytochrome P-450 CYP2C8 Substrates , Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A Inducers , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inducers , Cytochrome P-450 CYP3A4 Inducers (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Substrates , Diterpenes , Hypotensive Agents , Immunosuppressive Agents , Microtubule Inhibition , Microtubule Inhibitors , Mitosis Modulators , Myelosuppressive Agents , Narrow Therapeutic Index Drugs , Neurotoxic agents , OATP1B3 substrates , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Proteins , Taxane Derivatives , Taxoids , Terpenes , Tubulin Modulators